{"qid": "0", "sentence": "<e1> TRPV6 </e1> and <e2> prostate cancer </e2> : cancer growth beyond the prostate correlates with increased TRPV6 Ca2+ channel expression.", "e1": "TRPV6", "e2": "prostate cancer", "llm_pred": "0", "ground_truth": "1", "metapaths": [{"pathid": 8, "rel_score": -6.27117, "prob_score": -0.13410541, "relevant": "0", "stops": "TRPV6 - epithelium - prostate cancer", "reltypes": "EXPRESSES_AeG - LOCALIZES_DlA", "nodelabels": "Gene - Anatomy - Disease"}, {"pathid": 9, "rel_score": -7.45657, "prob_score": -0.117307775, "relevant": "0", "stops": "TRPV6 - seminal vesicle - prostate cancer", "reltypes": "EXPRESSES_AeG - LOCALIZES_DlA", "nodelabels": "Gene - Anatomy - Disease"}, {"pathid": 4, "rel_score": -7.52106, "prob_score": -0.15946077, "relevant": "0", "stops": "TRPV6 - TRAF1 - prostate cancer", "reltypes": "INTERACTS_GiG - ASSOCIATES_DaG", "nodelabels": "Gene - Gene - Disease"}, {"pathid": 2, "rel_score": -8.5237, "prob_score": -0.13295813, "relevant": "0", "stops": "TRPV6 - lymph node - prostate cancer", "reltypes": "EXPRESSES_AeG - LOCALIZES_DlA", "nodelabels": "Gene - Anatomy - Disease"}, {"pathid": 31, "rel_score": -8.52442, "prob_score": -0.11732201, "relevant": "0", "stops": "TRPV6 - vagina - SQRDL - Lenalidomide - Prostate cancer metastatic", "reltypes": "EXPRESSES_AeG - EXPRESSES_AeG - UPREGULATES_CuG - CAUSES_CcSE", "nodelabels": "Gene - Anatomy - Gene - Compound - SideEffect"}, {"pathid": 44, "rel_score": -8.65576, "prob_score": -0.1155343, "relevant": "0", "stops": "TRPV6 - medulla oblongata - SQRDL - Lenalidomide - Prostate cancer metastatic", "reltypes": "EXPRESSES_AeG - EXPRESSES_AeG - UPREGULATES_CuG - CAUSES_CcSE", "nodelabels": "Gene - Anatomy - Gene - Compound - SideEffect"}, {"pathid": 5, "rel_score": -8.79353, "prob_score": -0.113720424, "relevant": "0", "stops": "TRPV6 - renal system - prostate cancer", "reltypes": "EXPRESSES_AeG - LOCALIZES_DlA", "nodelabels": "Gene - Anatomy - Disease"}]}
{"qid": "1", "sentence": "Dual blockade of <e1> PKA </e1> and NF-\u03baB inhibits H2 relaxin-mediated castrate-resistant growth of <e2> prostate cancer </e2> sublines and induces apoptosis.", "e1": "PKA", "e2": "prostate cancer", "llm_pred": "0", "ground_truth": "0", "metapaths": [{"pathid": 12, "rel_score": 2.28253, "prob_score": -0.4381103, "relevant": "1", "stops": "PKIA - EGFR - prostate cancer", "reltypes": "INTERACTS_GiG - ASSOCIATES_DaG", "nodelabels": "Gene - Gene - Disease"}, {"pathid": 8, "rel_score": 2.19988, "prob_score": -0.5330633, "relevant": "1", "stops": "PKIA - bone marrow - prostate cancer", "reltypes": "EXPRESSES_AeG - LOCALIZES_DlA", "nodelabels": "Gene - Anatomy - Disease"}, {"pathid": 22, "rel_score": 2.15606, "prob_score": -0.47742718, "relevant": "1", "stops": "PKIA - bronchus - SQRDL - Lenalidomide - Prostate cancer metastatic", "reltypes": "EXPRESSES_AeG - EXPRESSES_AeG - UPREGULATES_CuG - CAUSES_CcSE", "nodelabels": "Gene - Anatomy - Gene - Compound - SideEffect"}, {"pathid": 16, "rel_score": 2.09455, "prob_score": -0.4638148, "relevant": "1", "stops": "PKIA - pituitary gland - SQRDL - Lenalidomide - Prostate cancer metastatic", "reltypes": "EXPRESSES_AeG - EXPRESSES_AeG - UPREGULATES_CuG - CAUSES_CcSE", "nodelabels": "Gene - Anatomy - Gene - Compound - SideEffect"}, {"pathid": 40, "rel_score": 1.87596, "prob_score": -0.45456883, "relevant": "1", "stops": "PKIA - thyroid gland - SQRDL - Lenalidomide - Prostate cancer metastatic", "reltypes": "EXPRESSES_AeG - EXPRESSES_AeG - UPREGULATES_CuG - CAUSES_CcSE", "nodelabels": "Gene - Anatomy - Gene - Compound - SideEffect"}, {"pathid": 11, "rel_score": 1.65599, "prob_score": -0.603874, "relevant": "1", "stops": "PKIA - PRKACB - prostate cancer", "reltypes": "INTERACTS_GiG - ASSOCIATES_DaG", "nodelabels": "Gene - Gene - Disease"}, {"pathid": 7, "rel_score": 1.55492, "prob_score": -0.6431172, "relevant": "1", "stops": "PKIA - EPRS - prostate cancer", "reltypes": "REGULATES_GrG - UPREGULATES_DuG", "nodelabels": "Gene - Gene - Disease"}]}
{"qid": "2", "sentence": "In human <e2> prostate cancer </e2> cells, knockdown of <e1> ILK </e1> expression with siRNA, or inhibition of ILK activity, results in significant inhibition of HIF-1alpha and VEGF expression.", "e1": "ILK", "e2": "prostate cancer", "llm_pred": "0", "ground_truth": "0", "metapaths": [{"pathid": 33, "rel_score": 3.93205, "prob_score": -0.2912336, "relevant": "1", "stops": "ILK - VIM - prostate cancer", "reltypes": "REGULATES_GrG - ASSOCIATES_DaG", "nodelabels": "Gene - Gene - Disease"}, {"pathid": 38, "rel_score": 3.51952, "prob_score": -0.34470868, "relevant": "1", "stops": "ILK - PRKCQ - prostate cancer", "reltypes": "REGULATES_GrG - ASSOCIATES_DaG", "nodelabels": "Gene - Gene - Disease"}, {"pathid": 41, "rel_score": 3.43371, "prob_score": -0.2543223, "relevant": "1", "stops": "ILK - seminal vesicle - prostate cancer", "reltypes": "EXPRESSES_AeG - LOCALIZES_DlA", "nodelabels": "Gene - Anatomy - Disease"}, {"pathid": 25, "rel_score": 3.2619, "prob_score": -0.3065708, "relevant": "1", "stops": "ILK - KLF6 - prostate cancer", "reltypes": "REGULATES_GrG - ASSOCIATES_DaG", "nodelabels": "Gene - Gene - Disease"}, {"pathid": 12, "rel_score": 2.90099, "prob_score": -0.2841307, "relevant": "1", "stops": "ILK - HSP90AB1 - prostate cancer", "reltypes": "INTERACTS_GiG - ASSOCIATES_DaG", "nodelabels": "Gene - Gene - Disease"}, {"pathid": 43, "rel_score": 2.75338, "prob_score": -0.36319256, "relevant": "1", "stops": "ILK - urethra - prostate cancer", "reltypes": "EXPRESSES_AeG - LOCALIZES_DlA", "nodelabels": "Gene - Anatomy - Disease"}, {"pathid": 36, "rel_score": 2.63553, "prob_score": -0.3794344, "relevant": "1", "stops": "ILK - CSRP1 - prostate cancer", "reltypes": "REGULATES_GrG - ASSOCIATES_DaG", "nodelabels": "Gene - Gene - Disease"}]}
{"qid": "3", "sentence": "Consistently, <e1> CLU </e1> expression was found to be significantly reduced in untreated and hormone-refractory human <e2> prostate carcinomas </e2> .", "e1": "CLU", "e2": "prostate carcinomas", "llm_pred": "0", "ground_truth": "0", "metapaths": [{"pathid": 46, "rel_score": 12.65342, "prob_score": -0.08112838, "relevant": "1", "stops": "CLUAP1 - female gonad - MCM6 - Paroxetine - Prostate carcinoma", "reltypes": "EXPRESSES_AeG - EXPRESSES_AeG - DOWNREGULATES_CdG - CAUSES_CcSE", "nodelabels": "Gene - Anatomy - Gene - Compound - SideEffect"}, {"pathid": 5, "rel_score": 12.63105, "prob_score": -0.07903144, "relevant": "1", "stops": "CLUAP1 - head - MCM6 - Paroxetine - Prostate carcinoma", "reltypes": "EXPRESSES_AeG - EXPRESSES_AeG - DOWNREGULATES_CdG - CAUSES_CcSE", "nodelabels": "Gene - Anatomy - Gene - Compound - SideEffect"}, {"pathid": 14, "rel_score": 12.3259, "prob_score": -0.08637491, "relevant": "1", "stops": "CLUAP1 - adipose tissue - MCM6 - Paroxetine - Prostate carcinoma", "reltypes": "EXPRESSES_AeG - EXPRESSES_AeG - DOWNREGULATES_CdG - CAUSES_CcSE", "nodelabels": "Gene - Anatomy - Gene - Compound - SideEffect"}, {"pathid": 39, "rel_score": 11.73021, "prob_score": -0.079169594, "relevant": "1", "stops": "CLUAP1 - cortex of kidney - MCM6 - Paroxetine - Prostate carcinoma", "reltypes": "EXPRESSES_AeG - EXPRESSES_AeG - DOWNREGULATES_CdG - CAUSES_CcSE", "nodelabels": "Gene - Anatomy - Gene - Compound - SideEffect"}, {"pathid": 41, "rel_score": 11.57809, "prob_score": -0.08524729, "relevant": "1", "stops": "CLUAP1 - lymph node - MCM6 - Paroxetine - Prostate carcinoma", "reltypes": "EXPRESSES_AeG - EXPRESSES_AeG - DOWNREGULATES_CdG - CAUSES_CcSE", "nodelabels": "Gene - Anatomy - Gene - Compound - SideEffect"}, {"pathid": 9, "rel_score": 11.56203, "prob_score": -0.08648779, "relevant": "1", "stops": "CLUAP1 - central nervous system - MCM6 - Paroxetine - Prostate carcinoma", "reltypes": "EXPRESSES_AeG - EXPRESSES_AeG - DOWNREGULATES_CdG - CAUSES_CcSE", "nodelabels": "Gene - Anatomy - Gene - Compound - SideEffect"}, {"pathid": 33, "rel_score": 11.18693, "prob_score": -0.089386985, "relevant": "1", "stops": "CLUAP1 - uterine cervix - MCM6 - Paroxetine - Prostate carcinoma", "reltypes": "EXPRESSES_AeG - EXPRESSES_AeG - DOWNREGULATES_CdG - CAUSES_CcSE", "nodelabels": "Gene - Anatomy - Gene - Compound - SideEffect"}]}
{"qid": "5", "sentence": "Up-regulation of <e1> c-Jun-NH2-kinase </e1> pathway contributes to the induction of mitochondria-mediated apoptosis by alpha-tocopheryl succinate in human <e2> prostate cancer </e2> cells.", "e1": "c-Jun-NH2-kinase", "e2": "prostate cancer", "llm_pred": "0", "ground_truth": "1", "metapaths": [{"pathid": 31, "rel_score": 1.4238, "prob_score": -0.49308798, "relevant": "0", "stops": "CPEB1 - testis - prostate cancer", "reltypes": "EXPRESSES_AeG - LOCALIZES_DlA", "nodelabels": "Gene - Anatomy - Disease"}, {"pathid": 33, "rel_score": -1.50225, "prob_score": -0.4578727, "relevant": "0", "stops": "CPEB1 - BCL2 - prostate cancer", "reltypes": "REGULATES_GrG - ASSOCIATES_DaG", "nodelabels": "Gene - Gene - Disease"}, {"pathid": 44, "rel_score": -1.75627, "prob_score": -0.5693917, "relevant": "0", "stops": "CPD - prostate gland - prostate cancer", "reltypes": "EXPRESSES_AeG - LOCALIZES_DlA", "nodelabels": "Gene - Anatomy - Disease"}, {"pathid": 37, "rel_score": -2.02803, "prob_score": -0.7024, "relevant": "1", "stops": "CPD - VAV3 - prostate cancer", "reltypes": "REGULATES_GrG - ASSOCIATES_DaG", "nodelabels": "Gene - Gene - Disease"}, {"pathid": 34, "rel_score": -2.18403, "prob_score": -0.6656734, "relevant": "0", "stops": "CPD - urethra - prostate cancer", "reltypes": "EXPRESSES_AeG - LOCALIZES_DlA", "nodelabels": "Gene - Anatomy - Disease"}, {"pathid": 27, "rel_score": -2.22583, "prob_score": -0.44927105, "relevant": "0", "stops": "CPEB1 - lymph node - prostate cancer", "reltypes": "EXPRESSES_AeG - LOCALIZES_DlA", "nodelabels": "Gene - Anatomy - Disease"}, {"pathid": 8, "rel_score": -2.35688, "prob_score": -0.42429134, "relevant": "0", "stops": "CPOX - seminal vesicle - prostate cancer", "reltypes": "EXPRESSES_AeG - LOCALIZES_DlA", "nodelabels": "Gene - Anatomy - Disease"}]}
{"qid": "6", "sentence": "In human <e2> prostate cancer </e2> cells, knockdown of ILK expression with siRNA, or inhibition of ILK activity, results in significant inhibition of <e1> HIF-1alpha </e1> and VEGF expression.", "e1": "HIF-1alpha", "e2": "prostate cancer", "llm_pred": "0", "ground_truth": "0", "metapaths": [{"pathid": 1, "rel_score": 3.81738, "prob_score": -0.2806321, "relevant": "1", "stops": "HIF1AN - SSR2 - prostate cancer", "reltypes": "REGULATES_GrG - ASSOCIATES_DaG", "nodelabels": "Gene - Gene - Disease"}, {"pathid": 14, "rel_score": 3.80778, "prob_score": -0.26719183, "relevant": "1", "stops": "HIF1AN - ADRB2 - prostate cancer", "reltypes": "REGULATES_GrG - ASSOCIATES_DaG", "nodelabels": "Gene - Gene - Disease"}, {"pathid": 0, "rel_score": 3.74265, "prob_score": -0.2619626, "relevant": "1", "stops": "HIF1AN - NCOA1 - prostate cancer", "reltypes": "REGULATES_GrG - ASSOCIATES_DaG", "nodelabels": "Gene - Gene - Disease"}, {"pathid": 20, "rel_score": 3.67471, "prob_score": -0.27212733, "relevant": "1", "stops": "HIF1AN - LDHB - prostate cancer", "reltypes": "REGULATES_GrG - ASSOCIATES_DaG", "nodelabels": "Gene - Gene - Disease"}, {"pathid": 13, "rel_score": 3.56341, "prob_score": -0.26262274, "relevant": "1", "stops": "HIF1AN - GDF15 - prostate cancer", "reltypes": "REGULATES_GrG - ASSOCIATES_DaG", "nodelabels": "Gene - Gene - Disease"}, {"pathid": 37, "rel_score": 3.30382, "prob_score": -0.30267614, "relevant": "1", "stops": "HIF1AN - SPAG4 - Imatinib - Prostate cancer", "reltypes": "REGULATES_GrG - UPREGULATES_CuG - CAUSES_CcSE", "nodelabels": "Gene - Gene - Compound - SideEffect"}, {"pathid": 47, "rel_score": 3.06843, "prob_score": -0.3259043, "relevant": "1", "stops": "HIF1AN - PUF60 - Riluzole - Prostate cancer", "reltypes": "REGULATES_GrG - DOWNREGULATES_CdG - CAUSES_CcSE", "nodelabels": "Gene - Gene - Compound - SideEffect"}]}
{"qid": "7", "sentence": "hTERT AS PS-ODN can significantly inhibit telomerase activity by downregulating the <e1> hTERT mRNA </e1> and protein expression, and inhibition of telomerase with hTERT antisense can enhance TNF-alpha-induced apoptosis of <e2> PC3 </e2> cells.", "e1": "hTERT mRNA", "e2": "PC3", "llm_pred": "0", "ground_truth": "1", "metapaths": [{"pathid": 27, "rel_score": -2.44063, "prob_score": -0.38002574, "relevant": "0", "stops": "TERT - POLR2I - Riluzole - Prostate cancer", "reltypes": "REGULATES_GrG - DOWNREGULATES_CdG - CAUSES_CcSE", "nodelabels": "Gene - Gene - Compound - SideEffect"}, {"pathid": 20, "rel_score": -2.44469, "prob_score": -0.4011876, "relevant": "0", "stops": "TERT - BLM - Paroxetine - Prostate cancer", "reltypes": "REGULATES_GrG - DOWNREGULATES_CdG - CAUSES_CcSE", "nodelabels": "Gene - Gene - Compound - SideEffect"}, {"pathid": 13, "rel_score": -2.49258, "prob_score": -0.40972707, "relevant": "0", "stops": "TERT - RUVBL1 - Testosterone - Prostate cancer", "reltypes": "INTERACTS_GiG - DOWNREGULATES_CdG - CAUSES_CcSE", "nodelabels": "Gene - Gene - Compound - SideEffect"}, {"pathid": 15, "rel_score": -2.62295, "prob_score": -0.4090512, "relevant": "0", "stops": "TERT - TLE1 - Testosterone - Prostate cancer", "reltypes": "REGULATES_GrG - DOWNREGULATES_CdG - CAUSES_CcSE", "nodelabels": "Gene - Gene - Compound - SideEffect"}, {"pathid": 7, "rel_score": -2.63137, "prob_score": -0.3812489, "relevant": "0", "stops": "TERT - breast cancer - Testosterone Propionate - Prostate cancer", "reltypes": "ASSOCIATES_DaG - PALLIATES_CpD - CAUSES_CcSE", "nodelabels": "Gene - Disease - Compound - SideEffect"}, {"pathid": 25, "rel_score": -2.85266, "prob_score": -0.350549, "relevant": "0", "stops": "TERT - TSTA3 - Imatinib - Prostate cancer", "reltypes": "REGULATES_GrG - DOWNREGULATES_CdG - CAUSES_CcSE", "nodelabels": "Gene - Gene - Compound - SideEffect"}, {"pathid": 3, "rel_score": -3.19428, "prob_score": -0.31306267, "relevant": "0", "stops": "TERT - ABL1 - Imatinib - Prostate cancer", "reltypes": "INTERACTS_GiG - BINDS_CbG - CAUSES_CcSE", "nodelabels": "Gene - Gene - Compound - SideEffect"}]}
{"qid": "8", "sentence": "In human <e2> prostate cancer </e2> cells, knockdown of ILK expression with siRNA, or inhibition of ILK activity, results in significant inhibition of HIF-1alpha and <e1> VEGF </e1> expression.", "e1": "VEGF", "e2": "prostate cancer", "llm_pred": "0", "ground_truth": "0", "metapaths": [{"pathid": 29, "rel_score": 6.23558, "prob_score": -0.1658753, "relevant": "1", "stops": "VEGFA - MAL - Imatinib - Prostate cancer", "reltypes": "REGULATES_GrG - UPREGULATES_CuG - CAUSES_CcSE", "nodelabels": "Gene - Gene - Compound - SideEffect"}, {"pathid": 32, "rel_score": 6.02845, "prob_score": -0.16037074, "relevant": "1", "stops": "VEGFA - ORM1 - Imatinib - Prostate cancer", "reltypes": "REGULATES_GrG - BINDS_CbG - CAUSES_CcSE", "nodelabels": "Gene - Gene - Compound - SideEffect"}, {"pathid": 8, "rel_score": 5.80653, "prob_score": -0.19307344, "relevant": "1", "stops": "VEGFA - BRCA1 - Paroxetine - Prostate cancer", "reltypes": "REGULATES_GrG - DOWNREGULATES_CdG - CAUSES_CcSE", "nodelabels": "Gene - Gene - Compound - SideEffect"}, {"pathid": 31, "rel_score": 5.79609, "prob_score": -0.17253135, "relevant": "1", "stops": "VEGFA - ORM1 - Mirabegron - Prostate cancer", "reltypes": "REGULATES_GrG - BINDS_CbG - CAUSES_CcSE", "nodelabels": "Gene - Gene - Compound - SideEffect"}, {"pathid": 27, "rel_score": 5.17947, "prob_score": -0.17221683, "relevant": "1", "stops": "VEGFA - LGMN - Testosterone - Prostate cancer", "reltypes": "REGULATES_GrG - UPREGULATES_CuG - CAUSES_CcSE", "nodelabels": "Gene - Gene - Compound - SideEffect"}, {"pathid": 6, "rel_score": 5.11404, "prob_score": -0.19553518, "relevant": "1", "stops": "VEGFA - RPS4Y1 - Paroxetine - Prostate cancer", "reltypes": "REGULATES_GrG - DOWNREGULATES_CdG - CAUSES_CcSE", "nodelabels": "Gene - Gene - Compound - SideEffect"}, {"pathid": 5, "rel_score": 4.91642, "prob_score": -0.20340331, "relevant": "1", "stops": "VEGFA - RAN - Paroxetine - Prostate cancer", "reltypes": "REGULATES_GrG - DOWNREGULATES_CdG - CAUSES_CcSE", "nodelabels": "Gene - Gene - Compound - SideEffect"}]}
{"qid": "9", "sentence": "hTERT AS PS-ODN can significantly inhibit telomerase activity by downregulating the <e1> hTERT mRNA </e1> and protein expression, and inhibition of telomerase with hTERT antisense can enhance TNF-alpha-induced apoptosis of <e2> PC3 </e2> cells.", "e1": "hTERT mRNA", "e2": "PC3", "llm_pred": "0", "ground_truth": "1", "metapaths": [{"pathid": 21, "rel_score": -2.18364, "prob_score": -0.44456866, "relevant": "0", "stops": "TERT - CDC25A - Paroxetine - Prostate cancer", "reltypes": "REGULATES_GrG - DOWNREGULATES_CdG - CAUSES_CcSE", "nodelabels": "Gene - Gene - Compound - SideEffect"}, {"pathid": 30, "rel_score": -2.24936, "prob_score": -0.38418332, "relevant": "0", "stops": "TERT - POLR2I - Paroxetine - Prostate cancer", "reltypes": "REGULATES_GrG - DOWNREGULATES_CdG - CAUSES_CcSE", "nodelabels": "Gene - Gene - Compound - SideEffect"}, {"pathid": 14, "rel_score": -2.39504, "prob_score": -0.41752777, "relevant": "0", "stops": "TERT - RUVBL1 - Paroxetine - Prostate cancer", "reltypes": "INTERACTS_GiG - DOWNREGULATES_CdG - CAUSES_CcSE", "nodelabels": "Gene - Gene - Compound - SideEffect"}, {"pathid": 10, "rel_score": -2.50357, "prob_score": -0.39943302, "relevant": "0", "stops": "TERT - LIG1 - Paroxetine - Prostate cancer", "reltypes": "REGULATES_GrG - DOWNREGULATES_CdG - CAUSES_CcSE", "nodelabels": "Gene - Gene - Compound - SideEffect"}, {"pathid": 26, "rel_score": -2.60295, "prob_score": -0.45794976, "relevant": "0", "stops": "TERT - FADS1 - Paroxetine - Prostate cancer", "reltypes": "REGULATES_GrG - UPREGULATES_CuG - CAUSES_CcSE", "nodelabels": "Gene - Gene - Compound - SideEffect"}, {"pathid": 2, "rel_score": -2.79861, "prob_score": -0.35731664, "relevant": "0", "stops": "TERT - RAN - Paroxetine - Prostate cancer", "reltypes": "REGULATES_GrG - DOWNREGULATES_CdG - CAUSES_CcSE", "nodelabels": "Gene - Gene - Compound - SideEffect"}, {"pathid": 6, "rel_score": -3.14643, "prob_score": -0.31781802, "relevant": "0", "stops": "TERT - breast cancer - Testosterone - Prostate cancer", "reltypes": "ASSOCIATES_DaG - PALLIATES_CpD - CAUSES_CcSE", "nodelabels": "Gene - Disease - Compound - SideEffect"}]}
{"qid": "10", "sentence": "Inhibition of the <e1> Akt </e1> , cyclooxygenase-2, and matrix metalloproteinase-9 pathways in combination with androgen deprivation therapy: potential therapeutic approaches for <e2> prostate cancer </e2> .", "e1": "Akt", "e2": "prostate cancer", "llm_pred": "0", "ground_truth": "1", "metapaths": [{"pathid": 24, "rel_score": -4.01865, "prob_score": -0.23908821, "relevant": "0", "stops": "AKT3 - GSK3B - prostate cancer", "reltypes": "INTERACTS_GiG - ASSOCIATES_DaG", "nodelabels": "Gene - Gene - Disease"}, {"pathid": 11, "rel_score": -4.02771, "prob_score": -0.24202926, "relevant": "0", "stops": "AKT3 - PCNA - prostate cancer", "reltypes": "REGULATES_GrG - UPREGULATES_DuG", "nodelabels": "Gene - Gene - Disease"}, {"pathid": 9, "rel_score": -4.13172, "prob_score": -0.2482768, "relevant": "0", "stops": "AKT3 - VIM - prostate cancer", "reltypes": "REGULATES_GrG - ASSOCIATES_DaG", "nodelabels": "Gene - Gene - Disease"}, {"pathid": 22, "rel_score": -4.18253, "prob_score": -0.24884495, "relevant": "0", "stops": "AKT3 - SERPINA3 - prostate cancer", "reltypes": "REGULATES_GrG - ASSOCIATES_DaG", "nodelabels": "Gene - Gene - Disease"}, {"pathid": 2, "rel_score": -4.25351, "prob_score": -0.23510101, "relevant": "0", "stops": "AKT3 - ADAM9 - prostate cancer", "reltypes": "REGULATES_GrG - ASSOCIATES_DaG", "nodelabels": "Gene - Gene - Disease"}, {"pathid": 33, "rel_score": -4.31984, "prob_score": -0.23149401, "relevant": "0", "stops": "AKT3 - PGRMC1 - prostate cancer", "reltypes": "REGULATES_GrG - ASSOCIATES_DaG", "nodelabels": "Gene - Gene - Disease"}, {"pathid": 36, "rel_score": -4.4603, "prob_score": -0.22419591, "relevant": "0", "stops": "AKT3 - hematologic cancer - Lenalidomide - Prostate cancer metastatic", "reltypes": "DOWNREGULATES_DdG - TREATS_CtD - CAUSES_CcSE", "nodelabels": "Gene - Disease - Compound - SideEffect"}]}
{"qid": "11", "sentence": "Our results demonstrated that 9-cis RA as a differentiating agent can arrest <e2> prostate cancer </e2> cells in G(1) phase and reduce cell mitosis, and upregulate the expression of <e1> human homeobox gene NKX3.1 </e1> , which is thought to play an important role in prostate differentiation and to act as a tumor suppressor gene in the prostate.", "e1": "human homeobox gene NKX3.1", "e2": "prostate cancer", "llm_pred": "0", "ground_truth": "1", "metapaths": [{"pathid": 18, "rel_score": -2.65943, "prob_score": -0.33460066, "relevant": "0", "stops": "NUMA1 - VIM - prostate cancer", "reltypes": "REGULATES_GrG - ASSOCIATES_DaG", "nodelabels": "Gene - Gene - Disease"}, {"pathid": 30, "rel_score": -2.68536, "prob_score": -0.37239295, "relevant": "0", "stops": "NUMA1 - Dasatinib - Infestation - Lenalidomide - Prostate cancer metastatic", "reltypes": "UPREGULATES_CuG - CAUSES_CcSE - CAUSES_CcSE - CAUSES_CcSE", "nodelabels": "Gene - Compound - SideEffect - Compound - SideEffect"}, {"pathid": 32, "rel_score": -2.82302, "prob_score": -0.35422793, "relevant": "0", "stops": "NUMA1 - Dasatinib - Dermatitis - Lenalidomide - Prostate cancer metastatic", "reltypes": "UPREGULATES_CuG - CAUSES_CcSE - CAUSES_CcSE - CAUSES_CcSE", "nodelabels": "Gene - Compound - SideEffect - Compound - SideEffect"}, {"pathid": 17, "rel_score": -2.98864, "prob_score": -0.3760206, "relevant": "0", "stops": "NUMA1 - PHGDH - prostate cancer", "reltypes": "REGULATES_GrG - ASSOCIATES_DaG", "nodelabels": "Gene - Gene - Disease"}, {"pathid": 48, "rel_score": -3.14179, "prob_score": -0.31828892, "relevant": "0", "stops": "NUMA1 - kidney - ABCB1 - Lenalidomide - Prostate cancer metastatic", "reltypes": "EXPRESSES_AeG - EXPRESSES_AeG - BINDS_CbG - CAUSES_CcSE", "nodelabels": "Gene - Anatomy - Gene - Compound - SideEffect"}, {"pathid": 27, "rel_score": -3.23918, "prob_score": -0.30871585, "relevant": "0", "stops": "NUMA1 - Vincristine - Dysuria - Lenalidomide - Prostate cancer metastatic", "reltypes": "DOWNREGULATES_CdG - CAUSES_CcSE - CAUSES_CcSE - CAUSES_CcSE", "nodelabels": "Gene - Compound - SideEffect - Compound - SideEffect"}, {"pathid": 23, "rel_score": -3.61167, "prob_score": -0.2768795, "relevant": "0", "stops": "NUMA1 - Vincristine - Bone marrow depression - Lenalidomide - Prostate cancer metastatic", "reltypes": "DOWNREGULATES_CdG - CAUSES_CcSE - CAUSES_CcSE - CAUSES_CcSE", "nodelabels": "Gene - Compound - SideEffect - Compound - SideEffect"}]}
{"qid": "12", "sentence": "DHT-induced E2F-1 protein and mRNA expressions was also inhibited by BMP-2, suggesting that BMP-2 inhibits DHT-induced growth of <e2> LNCaP </e2> cells through a decrease in <e1> E2F protein </e1> expression and suppression of E2F activity by hypophosphorylation of Rb.", "e1": "E2F protein", "e2": "LNCaP", "llm_pred": "0", "ground_truth": "1", "metapaths": [{"pathid": 4, "rel_score": -1.86195, "prob_score": -0.46718875, "relevant": "0", "stops": "E2F1 - SPON2 - prostate cancer", "reltypes": "REGULATES_GrG - ASSOCIATES_DaG", "nodelabels": "Gene - Gene - Disease"}, {"pathid": 35, "rel_score": -2.04817, "prob_score": -0.53707266, "relevant": "0", "stops": "E2F1 - APEX1 - prostate cancer", "reltypes": "REGULATES_GrG - ASSOCIATES_DaG", "nodelabels": "Gene - Gene - Disease"}, {"pathid": 7, "rel_score": -2.10482, "prob_score": -0.48823676, "relevant": "0", "stops": "E2F1 - lymph node - prostate cancer", "reltypes": "EXPRESSES_AeG - LOCALIZES_DlA", "nodelabels": "Gene - Anatomy - Disease"}, {"pathid": 0, "rel_score": -2.14046, "prob_score": -0.45924538, "relevant": "0", "stops": "E2F1 - SIRT1 - prostate cancer", "reltypes": "INTERACTS_GiG - ASSOCIATES_DaG", "nodelabels": "Gene - Gene - Disease"}, {"pathid": 45, "rel_score": -2.17746, "prob_score": -0.47509956, "relevant": "0", "stops": "E2F1 - DDB2 - Ruxolitinib - Prostate cancer", "reltypes": "INTERACTS_GiG - DOWNREGULATES_CdG - CAUSES_CcSE", "nodelabels": "Gene - Gene - Compound - SideEffect"}, {"pathid": 3, "rel_score": -2.2583, "prob_score": -0.44280848, "relevant": "0", "stops": "E2F1 - CXCL8 - prostate cancer", "reltypes": "REGULATES_GrG - ASSOCIATES_DaG", "nodelabels": "Gene - Gene - Disease"}, {"pathid": 32, "rel_score": -2.25984, "prob_score": -0.44250774, "relevant": "0", "stops": "E2F1 - AR - prostate cancer", "reltypes": "INTERACTS_GiG - ASSOCIATES_DaG", "nodelabels": "Gene - Gene - Disease"}]}
{"qid": "13", "sentence": "In surgically excised adult human prostate tissues, localized accumulations of <e1> TGF-beta1 </e1> are associated with <e2> prostate cancer </e2> and benign prostatic hyperplasia (BPH).", "e1": "TGF-beta1", "e2": "prostate cancer", "llm_pred": "0", "ground_truth": "0", "metapaths": [{"pathid": 41, "rel_score": 2.87704, "prob_score": -0.4034634, "relevant": "1", "stops": "TGFB1 - hematologic cancer - Ruxolitinib - Prostate cancer", "reltypes": "UPREGULATES_DuG - TREATS_CtD - CAUSES_CcSE", "nodelabels": "Gene - Disease - Compound - SideEffect"}, {"pathid": 38, "rel_score": 2.62488, "prob_score": -0.3894824, "relevant": "1", "stops": "TGFB1 - SPAG4 - Imatinib - Prostate cancer", "reltypes": "REGULATES_GrG - UPREGULATES_CuG - CAUSES_CcSE", "nodelabels": "Gene - Gene - Compound - SideEffect"}, {"pathid": 39, "rel_score": 2.56753, "prob_score": -0.38097468, "relevant": "1", "stops": "TGFB1 - SPAG4 - Testosterone - Prostate cancer", "reltypes": "REGULATES_GrG - UPREGULATES_CuG - CAUSES_CcSE", "nodelabels": "Gene - Gene - Compound - SideEffect"}, {"pathid": 26, "rel_score": 2.47856, "prob_score": -0.34758106, "relevant": "1", "stops": "TGFB1I1 - AR - Testosterone - Prostate cancer", "reltypes": "REGULATES_GrG - BINDS_CbG - CAUSES_CcSE", "nodelabels": "Gene - Gene - Compound - SideEffect"}, {"pathid": 45, "rel_score": 2.04939, "prob_score": -0.48794672, "relevant": "1", "stops": "TGFB1 - PAFAH1B3 - Testosterone Propionate - Prostate cancer", "reltypes": "REGULATES_GrG - DOWNREGULATES_CdG - CAUSES_CcSE", "nodelabels": "Gene - Gene - Compound - SideEffect"}, {"pathid": 3, "rel_score": 1.92771, "prob_score": -0.51875, "relevant": "1", "stops": "TGFB1I1 - EP300 - prostate cancer", "reltypes": "INTERACTS_GiG - ASSOCIATES_DaG", "nodelabels": "Gene - Gene - Disease"}, {"pathid": 34, "rel_score": 1.78031, "prob_score": -0.56169504, "relevant": "1", "stops": "TGFB1 - osteoporosis - Zoledronate - Prostate cancer", "reltypes": "ASSOCIATES_DaG - TREATS_CtD - CAUSES_CcSE", "nodelabels": "Gene - Disease - Compound - SideEffect"}]}
{"qid": "14", "sentence": "In human <e2> prostate cancer </e2> cells, knockdown of ILK expression with siRNA, or inhibition of ILK activity, results in significant inhibition of HIF-1alpha and <e1> VEGF </e1> expression.", "e1": "VEGF", "e2": "prostate cancer", "llm_pred": "0", "ground_truth": "0", "metapaths": [{"pathid": 29, "rel_score": 6.20309, "prob_score": -0.1658753, "relevant": "1", "stops": "VEGFA - MAL - Imatinib - Prostate cancer", "reltypes": "REGULATES_GrG - UPREGULATES_CuG - CAUSES_CcSE", "nodelabels": "Gene - Gene - Compound - SideEffect"}, {"pathid": 44, "rel_score": 6.02845, "prob_score": -0.18534751, "relevant": "1", "stops": "VEGFA - ZDHHC6 - Ruxolitinib - Prostate cancer", "reltypes": "REGULATES_GrG - DOWNREGULATES_CdG - CAUSES_CcSE", "nodelabels": "Gene - Gene - Compound - SideEffect"}, {"pathid": 49, "rel_score": 5.96445, "prob_score": -0.17639305, "relevant": "1", "stops": "VEGFA - PHKG2 - Ruxolitinib - Prostate cancer", "reltypes": "REGULATES_GrG - BINDS_CbG - CAUSES_CcSE", "nodelabels": "Gene - Gene - Compound - SideEffect"}, {"pathid": 48, "rel_score": 5.66926, "prob_score": -0.16120845, "relevant": "1", "stops": "VEGFA - MAPK9 - Ruxolitinib - Prostate cancer", "reltypes": "REGULATES_GrG - DOWNREGULATES_CdG - CAUSES_CcSE", "nodelabels": "Gene - Gene - Compound - SideEffect"}, {"pathid": 1, "rel_score": 5.3952, "prob_score": -0.16765732, "relevant": "1", "stops": "VEGFA - JADE2 - Lenalidomide - Prostate cancer metastatic", "reltypes": "REGULATES_GrG - UPREGULATES_CuG - CAUSES_CcSE", "nodelabels": "Gene - Gene - Compound - SideEffect"}, {"pathid": 28, "rel_score": 5.31745, "prob_score": -0.18805814, "relevant": "1", "stops": "VEGFA - LGMN - Testosterone Propionate - Prostate cancer", "reltypes": "REGULATES_GrG - UPREGULATES_CuG - CAUSES_CcSE", "nodelabels": "Gene - Gene - Compound - SideEffect"}, {"pathid": 11, "rel_score": 3.24433, "prob_score": -0.3082316, "relevant": "1", "stops": "VEGFA - Alzheimer's disease - Ropinirole - Prostate cancer", "reltypes": "ASSOCIATES_DaG - PALLIATES_CpD - CAUSES_CcSE", "nodelabels": "Gene - Disease - Compound - SideEffect"}]}
{"qid": "15", "sentence": "In <e2> PC-3 </e2> cells, adhesion molecule expression, analyzed by immunoblotting, was unaffected by LA, while a down-regulation of <e1> c-met </e1> (up to 28%) was observed after 24 h of treatment but which did not hold up over time (48-144 h).", "e1": "c-met", "e2": "PC-3", "llm_pred": "0", "ground_truth": "0", "metapaths": [{"pathid": 2, "rel_score": 15.27184, "prob_score": -0.07209363, "relevant": "1", "stops": "COMTD1 - urethra - prostate cancer", "reltypes": "EXPRESSES_AeG - LOCALIZES_DlA", "nodelabels": "Gene - Anatomy - Disease"}, {"pathid": 24, "rel_score": 14.58151, "prob_score": -0.068583064, "relevant": "1", "stops": "COMTD1 - pituitary gland - SQRDL - Lenalidomide - Prostate cancer metastatic", "reltypes": "EXPRESSES_AeG - EXPRESSES_AeG - UPREGULATES_CuG - CAUSES_CcSE", "nodelabels": "Gene - Anatomy - Gene - Compound - SideEffect"}, {"pathid": 12, "rel_score": 13.88696, "prob_score": -0.065483995, "relevant": "1", "stops": "COMTD1 - endocrine gland - SQRDL - Lenalidomide - Prostate cancer metastatic", "reltypes": "EXPRESSES_AeG - EXPRESSES_AeG - UPREGULATES_CuG - CAUSES_CcSE", "nodelabels": "Gene - Anatomy - Gene - Compound - SideEffect"}, {"pathid": 13, "rel_score": 13.87155, "prob_score": -0.07482165, "relevant": "1", "stops": "COMTD1 - cortex of kidney - SQRDL - Lenalidomide - Prostate cancer metastatic", "reltypes": "EXPRESSES_AeG - EXPRESSES_AeG - UPREGULATES_CuG - CAUSES_CcSE", "nodelabels": "Gene - Anatomy - Gene - Compound - SideEffect"}, {"pathid": 15, "rel_score": 13.36541, "prob_score": -0.07201056, "relevant": "1", "stops": "COMTD1 - lymph node - SQRDL - Lenalidomide - Prostate cancer metastatic", "reltypes": "EXPRESSES_AeG - EXPRESSES_AeG - UPREGULATES_CuG - CAUSES_CcSE", "nodelabels": "Gene - Anatomy - Gene - Compound - SideEffect"}, {"pathid": 8, "rel_score": 12.92992, "prob_score": -0.07734492, "relevant": "1", "stops": "COMTD1 - seminal vesicle - prostate cancer", "reltypes": "EXPRESSES_AeG - LOCALIZES_DlA", "nodelabels": "Gene - Anatomy - Disease"}, {"pathid": 40, "rel_score": 12.64223, "prob_score": -0.07910002, "relevant": "1", "stops": "COMTD1 - trachea - SQRDL - Lenalidomide - Prostate cancer metastatic", "reltypes": "EXPRESSES_AeG - EXPRESSES_AeG - UPREGULATES_CuG - CAUSES_CcSE", "nodelabels": "Gene - Anatomy - Gene - Compound - SideEffect"}]}
{"qid": "16", "sentence": "Transfection of the <e2> PC-3 </e2> prostate cell line with a dominant-negative form of p75( <e1> NTR </e1> ) before DIM treatment significantly rescued cell survival demonstrating a cause and effect relationship between DIM induction of p75(NTR) levels and inhibition of survival.", "e1": "NTR", "e2": "PC-3", "llm_pred": "1", "ground_truth": "1", "metapaths": [{"pathid": 29, "rel_score": 90.0901, "prob_score": -0.0111, "relevant": "1", "stops": "NKTR - adrenal gland - SQRDL - Lenalidomide - Prostate cancer metastatic", "reltypes": "EXPRESSES_AeG - EXPRESSES_AeG - UPREGULATES_CuG - CAUSES_CcSE", "nodelabels": "Gene - Anatomy - Gene - Compound - SideEffect"}, {"pathid": 27, "rel_score": 79.8085, "prob_score": -0.0133, "relevant": "1", "stops": "NKTR - mammary gland - SQRDL - Lenalidomide - Prostate cancer metastatic", "reltypes": "EXPRESSES_AeG - EXPRESSES_AeG - UPREGULATES_CuG - CAUSES_CcSE", "nodelabels": "Gene - Anatomy - Gene - Compound - SideEffect"}, {"pathid": 6, "rel_score": 79.7448, "prob_score": -0.0125, "relevant": "1", "stops": "NKTR - myometrium - SQRDL - Lenalidomide - Prostate cancer metastatic", "reltypes": "EXPRESSES_AeG - EXPRESSES_AeG - UPREGULATES_CuG - CAUSES_CcSE", "nodelabels": "Gene - Anatomy - Gene - Compound - SideEffect"}, {"pathid": 13, "rel_score": 76.1035, "prob_score": -0.0125, "relevant": "1", "stops": "NKTR - head - SQRDL - Lenalidomide - Prostate cancer metastatic", "reltypes": "EXPRESSES_AeG - EXPRESSES_AeG - UPREGULATES_CuG - CAUSES_CcSE", "nodelabels": "Gene - Anatomy - Gene - Compound - SideEffect"}, {"pathid": 15, "rel_score": 75.188, "prob_score": -0.0131, "relevant": "1", "stops": "NKTR - lymph node - SQRDL - Lenalidomide - Prostate cancer metastatic", "reltypes": "EXPRESSES_AeG - EXPRESSES_AeG - UPREGULATES_CuG - CAUSES_CcSE", "nodelabels": "Gene - Anatomy - Gene - Compound - SideEffect"}, {"pathid": 12, "rel_score": 63.8978, "prob_score": -0.0156, "relevant": "1", "stops": "NKTR - respiratory system - SQRDL - Lenalidomide - Prostate cancer metastatic", "reltypes": "EXPRESSES_AeG - EXPRESSES_AeG - UPREGULATES_CuG - CAUSES_CcSE", "nodelabels": "Gene - Anatomy - Gene - Compound - SideEffect"}, {"pathid": 4, "rel_score": 28.2646, "prob_score": -0.0354, "relevant": "1", "stops": "NKTR - renal system - prostate cancer", "reltypes": "EXPRESSES_AeG - LOCALIZES_DlA", "nodelabels": "Gene - Anatomy - Disease"}]}
{"qid": "17", "sentence": "DHT-induced <e1> E2F </e1> -1 protein and mRNA expressions was also inhibited by BMP-2, suggesting that BMP-2 inhibits DHT-induced growth of <e2> LNCaP </e2> cells through a decrease in E2F protein expression and suppression of E2F activity by hypophosphorylation of Rb.", "e1": "E2F", "e2": "LNCaP", "llm_pred": "0", "ground_truth": "1", "metapaths": [{"pathid": 20, "rel_score": 1.5086, "prob_score": -0.673883, "relevant": "0", "stops": "E2F1 - CREBBP - prostate cancer", "reltypes": "INTERACTS_GiG - ASSOCIATES_DaG", "nodelabels": "Gene - Gene - Disease"}, {"pathid": 12, "rel_score": -1.46529, "prob_score": -0.65152293, "relevant": "0", "stops": "E2F1 - MDM2 - prostate cancer", "reltypes": "INTERACTS_GiG - ASSOCIATES_DaG", "nodelabels": "Gene - Gene - Disease"}, {"pathid": 35, "rel_score": -1.48394, "prob_score": -0.6629, "relevant": "1", "stops": "E2F1 - APEX1 - prostate cancer", "reltypes": "REGULATES_GrG - ASSOCIATES_DaG", "nodelabels": "Gene - Gene - Disease"}, {"pathid": 41, "rel_score": -1.53487, "prob_score": -0.68245685, "relevant": "0", "stops": "E2F1 - PARP1 - prostate cancer", "reltypes": "INTERACTS_GiG - ASSOCIATES_DaG", "nodelabels": "Gene - Gene - Disease"}, {"pathid": 0, "rel_score": -1.53981, "prob_score": -0.64942527, "relevant": "0", "stops": "E2F1 - SIRT1 - prostate cancer", "reltypes": "INTERACTS_GiG - ASSOCIATES_DaG", "nodelabels": "Gene - Gene - Disease"}, {"pathid": 37, "rel_score": -1.56414, "prob_score": -0.6393319, "relevant": "0", "stops": "E2F1 - ESR1 - prostate cancer", "reltypes": "INTERACTS_GiG - ASSOCIATES_DaG", "nodelabels": "Gene - Gene - Disease"}, {"pathid": 14, "rel_score": -1.67252, "prob_score": -0.5978963, "relevant": "0", "stops": "E2F1 - DNMT1 - prostate cancer", "reltypes": "INTERACTS_GiG - ASSOCIATES_DaG", "nodelabels": "Gene - Gene - Disease"}]}
{"qid": "18", "sentence": "DHT-induced <e1> E2F-1 protein </e1> and mRNA expressions was also inhibited by BMP-2, suggesting that BMP-2 inhibits DHT-induced growth of <e2> LNCaP </e2> cells through a decrease in E2F protein expression and suppression of E2F activity by hypophosphorylation of Rb.", "e1": "E2F-1 protein", "e2": "LNCaP", "llm_pred": "0", "ground_truth": "1", "metapaths": [{"pathid": 15, "rel_score": -2.51813, "prob_score": -0.3564336, "relevant": "0", "stops": "E2F1 - MDM4 - prostate cancer", "reltypes": "INTERACTS_GiG - ASSOCIATES_DaG", "nodelabels": "Gene - Gene - Disease"}, {"pathid": 27, "rel_score": -2.57573, "prob_score": -0.3774811, "relevant": "0", "stops": "E2F1 - STX4 - prostate cancer", "reltypes": "REGULATES_GrG - ASSOCIATES_DaG", "nodelabels": "Gene - Gene - Disease"}, {"pathid": 32, "rel_score": -2.64915, "prob_score": -0.38823792, "relevant": "0", "stops": "E2F1 - AR - prostate cancer", "reltypes": "INTERACTS_GiG - ASSOCIATES_DaG", "nodelabels": "Gene - Gene - Disease"}, {"pathid": 2, "rel_score": -2.74529, "prob_score": -0.36426094, "relevant": "0", "stops": "E2F1 - GJA1 - prostate cancer", "reltypes": "REGULATES_GrG - ASSOCIATES_DaG", "nodelabels": "Gene - Gene - Disease"}, {"pathid": 1, "rel_score": -2.8056, "prob_score": -0.39711908, "relevant": "0", "stops": "E2F1 - BRCA1 - prostate cancer", "reltypes": "INTERACTS_GiG - ASSOCIATES_DaG", "nodelabels": "Gene - Gene - Disease"}, {"pathid": 28, "rel_score": -2.88467, "prob_score": -0.34666142, "relevant": "0", "stops": "E2F1 - SERPINA3 - prostate cancer", "reltypes": "REGULATES_GrG - ASSOCIATES_DaG", "nodelabels": "Gene - Gene - Disease"}, {"pathid": 40, "rel_score": -3.56024, "prob_score": -0.28087667, "relevant": "0", "stops": "E2F1 - BMP7 - prostate cancer", "reltypes": "INTERACTS_GiG - ASSOCIATES_DaG", "nodelabels": "Gene - Gene - Disease"}]}
{"qid": "19", "sentence": "<e1> GRP78 </e1> up-regulation is associated with androgen receptor status, Hsp70-Hsp90 client proteins and castrate-resistant <e2> prostate cancer </e2> .", "e1": "GRP78", "e2": "prostate cancer", "llm_pred": "0", "ground_truth": "0", "metapaths": [{"pathid": 6, "rel_score": 8.57339, "prob_score": -0.13045529, "relevant": "1", "stops": "GPR78 - RPN1 - prostate cancer", "reltypes": "REGULATES_GrG - UPREGULATES_DuG", "nodelabels": "Gene - Gene - Disease"}, {"pathid": 1, "rel_score": 7.71843, "prob_score": -0.11664023, "relevant": "1", "stops": "GPR78 - GTF2A2 - prostate cancer", "reltypes": "REGULATES_GrG - UPREGULATES_DuG", "nodelabels": "Gene - Gene - Disease"}, {"pathid": 15, "rel_score": 7.66519, "prob_score": -0.13421503, "relevant": "1", "stops": "GPR78 - CDC20 - SQRDL - Lenalidomide - Prostate cancer metastatic", "reltypes": "REGULATES_GrG - REGULATES_GrG - UPREGULATES_CuG - CAUSES_CcSE", "nodelabels": "Gene - Gene - Gene - Compound - SideEffect"}, {"pathid": 26, "rel_score": 7.54489, "prob_score": -0.13254236, "relevant": "1", "stops": "GPR78 - STUB1 - JADE2 - Lenalidomide - Prostate cancer metastatic", "reltypes": "REGULATES_GrG - REGULATES_GrG - UPREGULATES_CuG - CAUSES_CcSE", "nodelabels": "Gene - Gene - Gene - Compound - SideEffect"}, {"pathid": 33, "rel_score": 7.45045, "prob_score": -0.12955901, "relevant": "1", "stops": "GPR78 - female reproductive system - PAPD7 - Lenalidomide - Prostate cancer metastatic", "reltypes": "EXPRESSES_AeG - EXPRESSES_AeG - DOWNREGULATES_CdG - CAUSES_CcSE", "nodelabels": "Gene - Anatomy - Gene - Compound - SideEffect"}, {"pathid": 37, "rel_score": 7.40905, "prob_score": -0.13497393, "relevant": "1", "stops": "GPR78 - TYMS - PAPD7 - Lenalidomide - Prostate cancer metastatic", "reltypes": "REGULATES_GrG - REGULATES_GrG - DOWNREGULATES_CdG - CAUSES_CcSE", "nodelabels": "Gene - Gene - Gene - Compound - SideEffect"}, {"pathid": 9, "rel_score": 7.37409, "prob_score": -0.13561128, "relevant": "1", "stops": "GPR78 - female reproductive system - SQRDL - Lenalidomide - Prostate cancer metastatic", "reltypes": "EXPRESSES_AeG - EXPRESSES_AeG - UPREGULATES_CuG - CAUSES_CcSE", "nodelabels": "Gene - Anatomy - Gene - Compound - SideEffect"}]}
{"qid": "20", "sentence": "3,3'-diindolylmethane induction of p75NTR-dependent cell death via the <e1> p38 mitogen-activated protein kinase </e1> pathway in <e2> prostate cancer </e2> cells.", "e1": "p38 mitogen-activated protein kinase", "e2": "prostate cancer", "llm_pred": "1", "ground_truth": "1", "metapaths": [{"pathid": 5, "rel_score": 8.3022, "prob_score": -0.1418, "relevant": "1", "stops": "IPO8 - HSP90AB1 - prostate cancer", "reltypes": "INTERACTS_GiG - ASSOCIATES_DaG", "nodelabels": "Gene - Gene - Disease"}, {"pathid": 25, "rel_score": 7.5472, "prob_score": -0.1204, "relevant": "1", "stops": "IPO8 - liver - SQRDL - Lenalidomide - Prostate cancer metastatic", "reltypes": "EXPRESSES_AeG - EXPRESSES_AeG - UPREGULATES_CuG - CAUSES_CcSE", "nodelabels": "Gene - Anatomy - Gene - Compound - SideEffect"}, {"pathid": 22, "rel_score": 7.0507, "prob_score": -0.1551, "relevant": "1", "stops": "IPO8 - endometrium - SQRDL - Lenalidomide - Prostate cancer metastatic", "reltypes": "EXPRESSES_AeG - EXPRESSES_AeG - UPREGULATES_CuG - CAUSES_CcSE", "nodelabels": "Gene - Anatomy - Gene - Compound - SideEffect"}, {"pathid": 48, "rel_score": 6.4462, "prob_score": -0.1325, "relevant": "1", "stops": "IPO8 - urethra - SQRDL - Lenalidomide - Prostate cancer metastatic", "reltypes": "EXPRESSES_AeG - EXPRESSES_AeG - UPREGULATES_CuG - CAUSES_CcSE", "nodelabels": "Gene - Anatomy - Gene - Compound - SideEffect"}, {"pathid": 14, "rel_score": 6.3379, "prob_score": -0.1578, "relevant": "1", "stops": "IPO8 - medulla oblongata - SQRDL - Lenalidomide - Prostate cancer metastatic", "reltypes": "EXPRESSES_AeG - EXPRESSES_AeG - UPREGULATES_CuG - CAUSES_CcSE", "nodelabels": "Gene - Anatomy - Gene - Compound - SideEffect"}, {"pathid": 13, "rel_score": 5.781, "prob_score": -0.173, "relevant": "1", "stops": "IPO8 - thyroid gland - SQRDL - Lenalidomide - Prostate cancer metastatic", "reltypes": "EXPRESSES_AeG - EXPRESSES_AeG - UPREGULATES_CuG - CAUSES_CcSE", "nodelabels": "Gene - Anatomy - Gene - Compound - SideEffect"}, {"pathid": 7, "rel_score": 4.8776, "prob_score": -0.205, "relevant": "1", "stops": "IPO8 - bone marrow - prostate cancer", "reltypes": "EXPRESSES_AeG - LOCALIZES_DlA", "nodelabels": "Gene - Anatomy - Disease"}]}
{"qid": "21", "sentence": "Dual blockade of PKA and <e1> NF-\u03baB </e1> inhibits H2 relaxin-mediated castrate-resistant growth of <e2> prostate cancer </e2> sublines and induces apoptosis.", "e1": "NF-\u03baB", "e2": "prostate cancer", "llm_pred": "0", "ground_truth": "0", "metapaths": [{"pathid": 13, "rel_score": 2.1993, "prob_score": -0.46753255, "relevant": "1", "stops": "NFIB - MIF - prostate cancer", "reltypes": "REGULATES_GrG - ASSOCIATES_DaG", "nodelabels": "Gene - Gene - Disease"}, {"pathid": 27, "rel_score": 2.1389, "prob_score": -0.5882594, "relevant": "1", "stops": "NFIB - penis - prostate cancer", "reltypes": "EXPRESSES_AeG - LOCALIZES_DlA", "nodelabels": "Gene - Anatomy - Disease"}, {"pathid": 11, "rel_score": 2.06262, "prob_score": -0.48481828, "relevant": "1", "stops": "NFIB - ADI1 - prostate cancer", "reltypes": "REGULATES_GrG - ASSOCIATES_DaG", "nodelabels": "Gene - Gene - Disease"}, {"pathid": 43, "rel_score": 1.70436, "prob_score": -0.5867301, "relevant": "1", "stops": "NFIB - HDAC2 - Paroxetine - Prostate cancer", "reltypes": "REGULATES_GrG - DOWNREGULATES_CdG - CAUSES_CcSE", "nodelabels": "Gene - Gene - Compound - SideEffect"}, {"pathid": 39, "rel_score": 1.69993, "prob_score": -0.45469242, "relevant": "1", "stops": "NFIB - breast cancer - Testosterone - Prostate cancer", "reltypes": "DOWNREGULATES_DdG - PALLIATES_CpD - CAUSES_CcSE", "nodelabels": "Gene - Disease - Compound - SideEffect"}, {"pathid": 35, "rel_score": 1.61036, "prob_score": -0.62097716, "relevant": "1", "stops": "NFIB - SUZ12 - Testosterone Propionate - Prostate cancer", "reltypes": "REGULATES_GrG - DOWNREGULATES_CdG - CAUSES_CcSE", "nodelabels": "Gene - Gene - Compound - SideEffect"}, {"pathid": 31, "rel_score": 1.50299, "prob_score": -0.6653426, "relevant": "1", "stops": "NFIB - COTL1 - Paroxetine - Prostate cancer", "reltypes": "REGULATES_GrG - DOWNREGULATES_CdG - CAUSES_CcSE", "nodelabels": "Gene - Gene - Compound - SideEffect"}]}
{"qid": "22", "sentence": "In <e2> BPH </e2> samples there was a significant correlation between CD38 loss (mean 21% of acini) and <e1> HLA-DR </e1> up-regulation (mean 20%; P &lt; 0.001).", "e1": "HLA-DR", "e2": "BPH", "llm_pred": "0", "ground_truth": "0", "metapaths": [{"pathid": 7, "rel_score": 17.28608, "prob_score": -0.06784204, "relevant": "1", "stops": "HLA-DRA - RPN1 - prostate cancer", "reltypes": "REGULATES_GrG - UPREGULATES_DuG", "nodelabels": "Gene - Gene - Disease"}, {"pathid": 13, "rel_score": 15.68874, "prob_score": -0.06566067, "relevant": "1", "stops": "HLA-DRA - PIK3CG - prostate cancer", "reltypes": "REGULATES_GrG - ASSOCIATES_DaG", "nodelabels": "Gene - Gene - Disease"}, {"pathid": 25, "rel_score": 15.23229, "prob_score": -0.057854276, "relevant": "1", "stops": "HLA-DRA - EGFR - prostate cancer", "reltypes": "REGULATES_GrG - ASSOCIATES_DaG", "nodelabels": "Gene - Gene - Disease"}, {"pathid": 24, "rel_score": 15.22997, "prob_score": -0.06564734, "relevant": "1", "stops": "HLA-DRA - MYC - prostate cancer", "reltypes": "REGULATES_GrG - ASSOCIATES_DaG", "nodelabels": "Gene - Gene - Disease"}, {"pathid": 33, "rel_score": 14.74057, "prob_score": -0.063744254, "relevant": "1", "stops": "HLA-DRA - PARP1 - prostate cancer", "reltypes": "REGULATES_GrG - ASSOCIATES_DaG", "nodelabels": "Gene - Gene - Disease"}, {"pathid": 37, "rel_score": 13.34045, "prob_score": -0.07495915, "relevant": "1", "stops": "HLA-DRA - COTL1 - Paroxetine - Prostate cancer", "reltypes": "REGULATES_GrG - DOWNREGULATES_CdG - CAUSES_CcSE", "nodelabels": "Gene - Gene - Compound - SideEffect"}, {"pathid": 41, "rel_score": 13.00898, "prob_score": -0.07686994, "relevant": "1", "stops": "HLA-DRA - HSPA8 - Paroxetine - Prostate cancer", "reltypes": "REGULATES_GrG - DOWNREGULATES_CdG - CAUSES_CcSE", "nodelabels": "Gene - Gene - Compound - SideEffect"}]}
{"qid": "23", "sentence": "The absence of <e1> CD38 </e1> and presence of HLA-DR expression in prostatic epithelium is consistent in <e2> BPH </e2> and tissue surrounding tumour, and strongly related to gland atrophy.", "e1": "CD38", "e2": "BPH", "llm_pred": "0", "ground_truth": "0", "metapaths": [{"pathid": 1, "rel_score": 18.34526, "prob_score": -0.057628125, "relevant": "1", "stops": "CD38 - CD9 - prostate cancer", "reltypes": "INTERACTS_GiG - ASSOCIATES_DaG", "nodelabels": "Gene - Gene - Disease"}, {"pathid": 4, "rel_score": 18.03101, "prob_score": -0.054512274, "relevant": "1", "stops": "CD38 - LCK - Imatinib - Prostate cancer", "reltypes": "INTERACTS_GiG - BINDS_CbG - CAUSES_CcSE", "nodelabels": "Gene - Gene - Compound - SideEffect"}, {"pathid": 5, "rel_score": 17.66472, "prob_score": -0.055464495, "relevant": "1", "stops": "CD38 - hematologic cancer - Imatinib - Prostate cancer", "reltypes": "ASSOCIATES_DaG - TREATS_CtD - CAUSES_CcSE", "nodelabels": "Gene - Disease - Compound - SideEffect"}, {"pathid": 6, "rel_score": 17.55002, "prob_score": -0.05661447, "relevant": "1", "stops": "CD38 - hematologic cancer - Ruxolitinib - Prostate cancer", "reltypes": "ASSOCIATES_DaG - TREATS_CtD - CAUSES_CcSE", "nodelabels": "Gene - Disease - Compound - SideEffect"}, {"pathid": 3, "rel_score": 17.35207, "prob_score": -0.056977946, "relevant": "1", "stops": "CD38 - hematologic cancer - Lenalidomide - Prostate cancer metastatic", "reltypes": "ASSOCIATES_DaG - TREATS_CtD - CAUSES_CcSE", "nodelabels": "Gene - Disease - Compound - SideEffect"}, {"pathid": 2, "rel_score": 16.60027, "prob_score": -0.06024344, "relevant": "1", "stops": "CD38 - bone marrow - prostate cancer", "reltypes": "EXPRESSES_AeG - LOCALIZES_DlA", "nodelabels": "Gene - Anatomy - Disease"}, {"pathid": 0, "rel_score": 15.13775, "prob_score": -0.06605615, "relevant": "1", "stops": "CD38 - lymph node - prostate cancer", "reltypes": "EXPRESSES_AeG - LOCALIZES_DlA", "nodelabels": "Gene - Anatomy - Disease"}]}
{"qid": "24", "sentence": "Our findings demonstrate the efficacy of LA in upregulating E-cadherin, \u03b2- and <e1> \u03b3-catenin </e1> in <e2> LNCaP </e2> cells.", "e1": "\u03b3-catenin", "e2": "LNCaP", "llm_pred": "0", "ground_truth": "0", "metapaths": [{"pathid": 46, "rel_score": 8.94614, "prob_score": -0.114338204, "relevant": "1", "stops": "TARDBP - PCNA - prostate cancer", "reltypes": "REGULATES_GrG - UPREGULATES_DuG", "nodelabels": "Gene - Gene - Disease"}, {"pathid": 5, "rel_score": 8.90869, "prob_score": -0.11178318, "relevant": "1", "stops": "TP73 - MYC - prostate cancer", "reltypes": "INTERACTS_GiG - ASSOCIATES_DaG", "nodelabels": "Gene - Gene - Disease"}, {"pathid": 8, "rel_score": 8.9071, "prob_score": -0.11226888, "relevant": "1", "stops": "TP73 - MDM2 - prostate cancer", "reltypes": "INTERACTS_GiG - ASSOCIATES_DaG", "nodelabels": "Gene - Gene - Disease"}, {"pathid": 23, "rel_score": 8.74585, "prob_score": -0.12040908, "relevant": "1", "stops": "TMEM14C - urethra - prostate cancer", "reltypes": "EXPRESSES_AeG - LOCALIZES_DlA", "nodelabels": "Gene - Anatomy - Disease"}, {"pathid": 37, "rel_score": 8.30496, "prob_score": -0.11224634, "relevant": "1", "stops": "TARDBP - TYMS - prostate cancer", "reltypes": "REGULATES_GrG - ASSOCIATES_DaG", "nodelabels": "Gene - Gene - Disease"}, {"pathid": 25, "rel_score": 8.25491, "prob_score": -0.12114286, "relevant": "1", "stops": "TMEM14C - renal system - prostate cancer", "reltypes": "EXPRESSES_AeG - LOCALIZES_DlA", "nodelabels": "Gene - Anatomy - Disease"}, {"pathid": 16, "rel_score": 8.14332, "prob_score": -0.122801036, "relevant": "1", "stops": "TMUB2 - BRCA1 - prostate cancer", "reltypes": "COVARIES_GcG - ASSOCIATES_DaG", "nodelabels": "Gene - Gene - Disease"}]}
{"qid": "25", "sentence": "Transfection of the <e2> PC-3 </e2> prostate cell line with a dominant-negative form of <e1> p75 </e1> (NTR) before DIM treatment significantly rescued cell survival demonstrating a cause and effect relationship between DIM induction of p75(NTR) levels and inhibition of survival.", "e1": "p75", "e2": "PC-3", "llm_pred": "1", "ground_truth": "1", "metapaths": [{"pathid": 29, "rel_score": 126.1034, "prob_score": -0.0079, "relevant": "1", "stops": "GPR75-ASB3 - CUL5 - HSP90AB1 - prostate cancer", "reltypes": "INTERACTS_GiG - INTERACTS_GiG - ASSOCIATES_DaG", "nodelabels": "Gene - Gene - Gene - Disease"}, {"pathid": 35, "rel_score": 125.1564, "prob_score": -0.0082, "relevant": "1", "stops": "GPR75-ASB3 - CUL5 - RPL14 - prostate cancer", "reltypes": "INTERACTS_GiG - INTERACTS_GiG - UPREGULATES_DuG", "nodelabels": "Gene - Gene - Gene - Disease"}, {"pathid": 19, "rel_score": 122.1001, "prob_score": -0.008, "relevant": "1", "stops": "GPR75-ASB3 - HSP90AA1 - UROD - prostate cancer", "reltypes": "INTERACTS_GiG - REGULATES_GrG - DOWNREGULATES_DdG", "nodelabels": "Gene - Gene - Gene - Disease"}, {"pathid": 7, "rel_score": 121.9512, "prob_score": -0.0084, "relevant": "1", "stops": "GPR75-ASB3 - HSP90AA1 - GRK6 - prostate cancer", "reltypes": "INTERACTS_GiG - INTERACTS_GiG - UPREGULATES_DuG", "nodelabels": "Gene - Gene - Gene - Disease"}, {"pathid": 40, "rel_score": 118.3432, "prob_score": -0.0082, "relevant": "1", "stops": "GPR75-ASB3 - HSP90AA1 - HSPA1A - prostate cancer", "reltypes": "INTERACTS_GiG - INTERACTS_GiG - ASSOCIATES_DaG", "nodelabels": "Gene - Gene - Gene - Disease"}, {"pathid": 14, "rel_score": 117.096, "prob_score": -0.0085, "relevant": "1", "stops": "GPR75-ASB3 - HSP90AA1 - MIF - prostate cancer", "reltypes": "INTERACTS_GiG - REGULATES_GrG - ASSOCIATES_DaG", "nodelabels": "Gene - Gene - Gene - Disease"}, {"pathid": 1, "rel_score": 115.4734, "prob_score": -0.0087, "relevant": "1", "stops": "GPR75-ASB3 - HSP90AA1 - TOP2A - prostate cancer", "reltypes": "INTERACTS_GiG - REGULATES_GrG - ASSOCIATES_DaG", "nodelabels": "Gene - Gene - Gene - Disease"}]}
{"qid": "26", "sentence": "Moreover, 76% of all CD38-negative acini in <e2> BPH </e2> had <e1> HLA-DR </e1> up-regulation in the same prostate epithelial cells, predominantly in atrophic and cystic glands, and in cells with retained secretions (74%).", "e1": "HLA-DR", "e2": "BPH", "llm_pred": "0", "ground_truth": "0", "metapaths": [{"pathid": 7, "rel_score": 14.89425, "prob_score": -0.074218154, "relevant": "1", "stops": "HLA-DRA - RPN1 - prostate cancer", "reltypes": "REGULATES_GrG - UPREGULATES_DuG", "nodelabels": "Gene - Gene - Disease"}, {"pathid": 39, "rel_score": 14.83459, "prob_score": -0.06741224, "relevant": "1", "stops": "HLA-DRA - IL4R - Riluzole - Prostate cancer", "reltypes": "REGULATES_GrG - UPREGULATES_CuG - CAUSES_CcSE", "nodelabels": "Gene - Gene - Compound - SideEffect"}, {"pathid": 12, "rel_score": 14.48645, "prob_score": -0.069025196, "relevant": "1", "stops": "HLA-DRA - AKT1 - prostate cancer", "reltypes": "REGULATES_GrG - ASSOCIATES_DaG", "nodelabels": "Gene - Gene - Disease"}, {"pathid": 17, "rel_score": 13.47346, "prob_score": -0.06713522, "relevant": "1", "stops": "HLA-DRA - TGFBR2 - prostate cancer", "reltypes": "REGULATES_GrG - ASSOCIATES_DaG", "nodelabels": "Gene - Gene - Disease"}, {"pathid": 22, "rel_score": 13.24503, "prob_score": -0.07549579, "relevant": "1", "stops": "HLA-DRA - bone marrow - prostate cancer", "reltypes": "EXPRESSES_AeG - LOCALIZES_DlA", "nodelabels": "Gene - Anatomy - Disease"}, {"pathid": 43, "rel_score": 13.22401, "prob_score": -0.075619705, "relevant": "1", "stops": "HLA-DRA - TIMM9 - Testosterone - Prostate cancer", "reltypes": "REGULATES_GrG - DOWNREGULATES_CdG - CAUSES_CcSE", "nodelabels": "Gene - Gene - Compound - SideEffect"}, {"pathid": 23, "rel_score": 12.39465, "prob_score": -0.08067622, "relevant": "1", "stops": "HLA-DRA - testis - prostate cancer", "reltypes": "EXPRESSES_AeG - LOCALIZES_DlA", "nodelabels": "Gene - Anatomy - Disease"}]}
{"qid": "27", "sentence": "These data suggest that blocking <e1> TSPO </e1> function in tumor cells induces cell death and denotes a survival role for TSPO in <e2> prostate cancer </e2> and provides the first evidence for the use of benzodiazepines in prostate cancer therapeutics.", "e1": "TSPO", "e2": "prostate cancer", "llm_pred": "0", "ground_truth": "1", "metapaths": [{"pathid": 3, "rel_score": -3.97219, "prob_score": -0.23479232, "relevant": "0", "stops": "TSPO - urethra - prostate cancer", "reltypes": "EXPRESSES_AeG - LOCALIZES_DlA", "nodelabels": "Gene - Anatomy - Disease"}, {"pathid": 17, "rel_score": -4.02739, "prob_score": -0.24830073, "relevant": "0", "stops": "TSPO - Clonazepam - Rhinitis - Lenalidomide - Prostate cancer metastatic", "reltypes": "BINDS_CbG - CAUSES_CcSE - CAUSES_CcSE - CAUSES_CcSE", "nodelabels": "Gene - Compound - SideEffect - Compound - SideEffect"}, {"pathid": 36, "rel_score": -4.25913, "prob_score": -0.22475296, "relevant": "0", "stops": "TSPO - Eszopiclone - Dysuria - Lenalidomide - Prostate cancer metastatic", "reltypes": "BINDS_CbG - CAUSES_CcSE - CAUSES_CcSE - CAUSES_CcSE", "nodelabels": "Gene - Compound - SideEffect - Compound - SideEffect"}, {"pathid": 33, "rel_score": -4.27533, "prob_score": -0.233901, "relevant": "0", "stops": "TSPO - Triazolam - Dysuria - Lenalidomide - Prostate cancer metastatic", "reltypes": "BINDS_CbG - CAUSES_CcSE - CAUSES_CcSE - CAUSES_CcSE", "nodelabels": "Gene - Compound - SideEffect - Compound - SideEffect"}, {"pathid": 15, "rel_score": -4.44939, "prob_score": -0.25175047, "relevant": "0", "stops": "TSPO - Diazepam - Rhinitis - Lenalidomide - Prostate cancer metastatic", "reltypes": "BINDS_CbG - CAUSES_CcSE - CAUSES_CcSE - CAUSES_CcSE", "nodelabels": "Gene - Compound - SideEffect - Compound - SideEffect"}, {"pathid": 12, "rel_score": -4.68867, "prob_score": -0.21327512, "relevant": "0", "stops": "TSPO2 - bone marrow - prostate cancer", "reltypes": "EXPRESSES_AeG - LOCALIZES_DlA", "nodelabels": "Gene - Anatomy - Disease"}, {"pathid": 24, "rel_score": -4.79869, "prob_score": -0.20838736, "relevant": "0", "stops": "TSPO - Zopiclone - Gynaecomastia - Lenalidomide - Prostate cancer metastatic", "reltypes": "BINDS_CbG - CAUSES_CcSE - CAUSES_CcSE - CAUSES_CcSE", "nodelabels": "Gene - Compound - SideEffect - Compound - SideEffect"}]}
{"qid": "29", "sentence": "Inhibition of <e1> ILK </e1> activity also inhibits <e2> prostate tumor </e2> angiogenesis and suppresses tumor growth.", "e1": "ILK", "e2": "prostate tumor", "llm_pred": "1", "ground_truth": "1", "metapaths": [{"pathid": 26, "rel_score": 4.8077, "prob_score": -0.2228, "relevant": "1", "stops": "ILK - CDKN1B - prostate cancer", "reltypes": "REGULATES_GrG - ASSOCIATES_DaG", "nodelabels": "Gene - Gene - Disease"}, {"pathid": 37, "rel_score": 4.7409, "prob_score": -0.2309, "relevant": "1", "stops": "ILK - ITGB3 - prostate cancer", "reltypes": "INTERACTS_GiG - ASSOCIATES_DaG", "nodelabels": "Gene - Gene - Disease"}, {"pathid": 3, "rel_score": 4.498, "prob_score": -0.208, "relevant": "1", "stops": "ILK - RPN1 - prostate cancer", "reltypes": "REGULATES_GrG - UPREGULATES_DuG", "nodelabels": "Gene - Gene - Disease"}, {"pathid": 11, "rel_score": 4.4883, "prob_score": -0.2223, "relevant": "1", "stops": "ILK - VAV3 - prostate cancer", "reltypes": "REGULATES_GrG - ASSOCIATES_DaG", "nodelabels": "Gene - Gene - Disease"}, {"pathid": 5, "rel_score": 4.3305, "prob_score": -0.2109, "relevant": "1", "stops": "ILK - ELAC2 - prostate cancer", "reltypes": "REGULATES_GrG - ASSOCIATES_DaG", "nodelabels": "Gene - Gene - Disease"}, {"pathid": 6, "rel_score": 4.2972, "prob_score": -0.2327, "relevant": "1", "stops": "ILK - MIF - prostate cancer", "reltypes": "INTERACTS_GiG - ASSOCIATES_DaG", "nodelabels": "Gene - Gene - Disease"}, {"pathid": 21, "rel_score": 4.1537, "prob_score": -0.2408, "relevant": "1", "stops": "ILK - ERBB3 - prostate cancer", "reltypes": "REGULATES_GrG - ASSOCIATES_DaG", "nodelabels": "Gene - Gene - Disease"}]}
{"qid": "31", "sentence": "Constitutive activation of MAPK/ERK inhibits <e2> prostate cancer </e2> cell proliferation through upregulation of <e1> BRCA2 </e1> .", "e1": "BRCA2", "e2": "prostate cancer", "llm_pred": "0", "ground_truth": "1", "metapaths": [{"pathid": 15, "rel_score": -1.67381, "prob_score": -0.48022106, "relevant": "0", "stops": "BRCA2 - endocrine gland - SQRDL - Lenalidomide - Prostate cancer metastatic", "reltypes": "EXPRESSES_AeG - EXPRESSES_AeG - UPREGULATES_CuG - CAUSES_CcSE", "nodelabels": "Gene - Anatomy - Gene - Compound - SideEffect"}, {"pathid": 43, "rel_score": -1.83439, "prob_score": -0.52393585, "relevant": "0", "stops": "BRCA2 - testis - JADE2 - Lenalidomide - Prostate cancer metastatic", "reltypes": "EXPRESSES_AeG - EXPRESSES_AeG - UPREGULATES_CuG - CAUSES_CcSE", "nodelabels": "Gene - Anatomy - Gene - Compound - SideEffect"}, {"pathid": 1, "rel_score": -1.90862, "prob_score": -0.54514205, "relevant": "0", "stops": "BRCA2 - bone marrow - SQRDL - Lenalidomide - Prostate cancer metastatic", "reltypes": "EXPRESSES_AeG - EXPRESSES_AeG - UPREGULATES_CuG - CAUSES_CcSE", "nodelabels": "Gene - Anatomy - Gene - Compound - SideEffect"}, {"pathid": 30, "rel_score": -2.08238, "prob_score": -0.5974394, "relevant": "0", "stops": "BRCA2 - brain - SQRDL - Lenalidomide - Prostate cancer metastatic", "reltypes": "DOWNREGULATES_AdG - EXPRESSES_AeG - UPREGULATES_CuG - CAUSES_CcSE", "nodelabels": "Gene - Anatomy - Gene - Compound - SideEffect"}, {"pathid": 5, "rel_score": -2.0967, "prob_score": -0.4769384, "relevant": "0", "stops": "BRCA2 - lymph node - SQRDL - Lenalidomide - Prostate cancer metastatic", "reltypes": "EXPRESSES_AeG - EXPRESSES_AeG - UPREGULATES_CuG - CAUSES_CcSE", "nodelabels": "Gene - Anatomy - Gene - Compound - SideEffect"}, {"pathid": 13, "rel_score": -2.11493, "prob_score": -0.47282523, "relevant": "0", "stops": "BRCA2 - endometrium - SQRDL - Lenalidomide - Prostate cancer metastatic", "reltypes": "EXPRESSES_AeG - EXPRESSES_AeG - UPREGULATES_CuG - CAUSES_CcSE", "nodelabels": "Gene - Anatomy - Gene - Compound - SideEffect"}, {"pathid": 38, "rel_score": -2.13124, "prob_score": -0.46920827, "relevant": "0", "stops": "BRCA2 - adrenal gland - JADE2 - Lenalidomide - Prostate cancer metastatic", "reltypes": "EXPRESSES_AeG - EXPRESSES_AeG - UPREGULATES_CuG - CAUSES_CcSE", "nodelabels": "Gene - Anatomy - Gene - Compound - SideEffect"}]}
{"qid": "32", "sentence": "Inhibition of <e1> telomerase </e1> with human telomerase reverse transcriptase antisense increases the sensitivity of tumor necrosis factor-alpha-induced apoptosis in <e2> prostate cancer </e2> cells.", "e1": "telomerase", "e2": "prostate cancer", "llm_pred": "1", "ground_truth": "1", "metapaths": [{"pathid": 8, "rel_score": 1.7776, "prob_score": -0.5626, "relevant": "1", "stops": "EOMES - multiple sclerosis - Pregabalin - Prostate cancer", "reltypes": "ASSOCIATES_DaG - PALLIATES_CpD - CAUSES_CcSE", "nodelabels": "Gene - Disease - Compound - SideEffect"}, {"pathid": 2, "rel_score": 1.7711, "prob_score": -0.5831, "relevant": "1", "stops": "EOMES - TGFB1 - prostate cancer", "reltypes": "COVARIES_GcG - ASSOCIATES_DaG", "nodelabels": "Gene - Gene - Disease"}, {"pathid": 0, "rel_score": 1.7197, "prob_score": -0.6029, "relevant": "1", "stops": "EOMES - lymph node - prostate cancer", "reltypes": "EXPRESSES_AeG - LOCALIZES_DlA", "nodelabels": "Gene - Anatomy - Disease"}, {"pathid": 3, "rel_score": 1.7151, "prob_score": -0.5646, "relevant": "1", "stops": "EOMES - bone marrow - prostate cancer", "reltypes": "EXPRESSES_AeG - LOCALIZES_DlA", "nodelabels": "Gene - Anatomy - Disease"}, {"pathid": 5, "rel_score": 1.6585, "prob_score": -0.5815, "relevant": "1", "stops": "EOMES - hematologic cancer - Lenalidomide - Prostate cancer metastatic", "reltypes": "ASSOCIATES_DaG - TREATS_CtD - CAUSES_CcSE", "nodelabels": "Gene - Disease - Compound - SideEffect"}, {"pathid": 7, "rel_score": 1.5942, "prob_score": -0.6273, "relevant": "1", "stops": "EOMES - hematologic cancer - Ruxolitinib - Prostate cancer", "reltypes": "ASSOCIATES_DaG - TREATS_CtD - CAUSES_CcSE", "nodelabels": "Gene - Disease - Compound - SideEffect"}, {"pathid": 6, "rel_score": 1.5135, "prob_score": -0.6607, "relevant": "1", "stops": "EOMES - hematologic cancer - Imatinib - Prostate cancer", "reltypes": "ASSOCIATES_DaG - TREATS_CtD - CAUSES_CcSE", "nodelabels": "Gene - Disease - Compound - SideEffect"}]}
{"qid": "35", "sentence": "Immunohistochemical analysis of tissue microarrays in combination with multispectral quantitative imaging comparing <e1> RLN2 </e1> levels in patients with benign prostatic hyperplasia ( <e2> BPH </e2> ), prostatic intraepithelial neoplasia, and CaP determined that RLN2 is significantly upregulated in CaP vs BPH (p = 0.002).", "e1": "RLN2", "e2": "BPH", "llm_pred": "0", "ground_truth": "0", "metapaths": [{"pathid": 2, "rel_score": 17.61494, "prob_score": -0.06503409, "relevant": "1", "stops": "RLN2 - prostate gland - SQRDL - Lenalidomide - Prostate cancer metastatic", "reltypes": "EXPRESSES_AeG - EXPRESSES_AeG - UPREGULATES_CuG - CAUSES_CcSE", "nodelabels": "Gene - Anatomy - Gene - Compound - SideEffect"}, {"pathid": 11, "rel_score": 15.56178, "prob_score": -0.0646976, "relevant": "1", "stops": "RLN2 - nervous system - JADE2 - Lenalidomide - Prostate cancer metastatic", "reltypes": "EXPRESSES_AeG - EXPRESSES_AeG - UPREGULATES_CuG - CAUSES_CcSE", "nodelabels": "Gene - Anatomy - Gene - Compound - SideEffect"}, {"pathid": 37, "rel_score": 15.45595, "prob_score": -0.06425528, "relevant": "1", "stops": "RLN2 - regulation of angiogenesis - PTGS2 - Lenalidomide - Prostate cancer metastatic", "reltypes": "PARTICIPATES_GpBP - PARTICIPATES_GpBP - BINDS_CbG - CAUSES_CcSE", "nodelabels": "Gene - BiologicalProcess - Gene - Compound - SideEffect"}, {"pathid": 19, "rel_score": 15.37752, "prob_score": -0.056766648, "relevant": "1", "stops": "RLN2 - prostate cancer - TNFSF11 - Lenalidomide - Prostate cancer metastatic", "reltypes": "ASSOCIATES_DaG - ASSOCIATES_DaG - BINDS_CbG - CAUSES_CcSE", "nodelabels": "Gene - Disease - Gene - Compound - SideEffect"}, {"pathid": 5, "rel_score": 15.14693, "prob_score": -0.06601634, "relevant": "1", "stops": "RLN2 - nervous system - SQRDL - Lenalidomide - Prostate cancer metastatic", "reltypes": "EXPRESSES_AeG - EXPRESSES_AeG - UPREGULATES_CuG - CAUSES_CcSE", "nodelabels": "Gene - Anatomy - Gene - Compound - SideEffect"}, {"pathid": 30, "rel_score": 14.65846, "prob_score": -0.06822108, "relevant": "1", "stops": "RLN2 - regulation of vasculature development - PTGS2 - Lenalidomide - Prostate cancer metastatic", "reltypes": "PARTICIPATES_GpBP - PARTICIPATES_GpBP - BINDS_CbG - CAUSES_CcSE", "nodelabels": "Gene - BiologicalProcess - Gene - Compound - SideEffect"}, {"pathid": 29, "rel_score": 13.94895, "prob_score": -0.07169176, "relevant": "1", "stops": "RLN2 - multi-organism reproductive process - PTGS2 - Lenalidomide - Prostate cancer metastatic", "reltypes": "PARTICIPATES_GpBP - PARTICIPATES_GpBP - BINDS_CbG - CAUSES_CcSE", "nodelabels": "Gene - BiologicalProcess - Gene - Compound - SideEffect"}]}
{"qid": "36", "sentence": "In human <e2> prostate cancer </e2> cells, knockdown of <e1> ILK </e1> expression with siRNA, or inhibition of ILK activity, results in significant inhibition of HIF-1alpha and VEGF expression.", "e1": "ILK", "e2": "prostate cancer", "llm_pred": "0", "ground_truth": "0", "metapaths": [{"pathid": 21, "rel_score": 3.781, "prob_score": -0.33821338, "relevant": "1", "stops": "ILK - ERBB3 - prostate cancer", "reltypes": "REGULATES_GrG - ASSOCIATES_DaG", "nodelabels": "Gene - Gene - Disease"}, {"pathid": 26, "rel_score": 3.33089, "prob_score": -0.26448345, "relevant": "1", "stops": "ILK - CDKN1B - prostate cancer", "reltypes": "REGULATES_GrG - ASSOCIATES_DaG", "nodelabels": "Gene - Gene - Disease"}, {"pathid": 10, "rel_score": 3.06222, "prob_score": -0.32655948, "relevant": "1", "stops": "ILK - DIABLO - prostate cancer", "reltypes": "REGULATES_GrG - ASSOCIATES_DaG", "nodelabels": "Gene - Gene - Disease"}, {"pathid": 42, "rel_score": 2.95674, "prob_score": -0.30022013, "relevant": "1", "stops": "ILK - TGFBR2 - prostate cancer", "reltypes": "REGULATES_GrG - ASSOCIATES_DaG", "nodelabels": "Gene - Gene - Disease"}, {"pathid": 34, "rel_score": 2.8177, "prob_score": -0.35489872, "relevant": "1", "stops": "ILK - SLC7A1 - prostate cancer", "reltypes": "REGULATES_GrG - ASSOCIATES_DaG", "nodelabels": "Gene - Gene - Disease"}, {"pathid": 5, "rel_score": 2.68053, "prob_score": -0.3730594, "relevant": "1", "stops": "ILK - ELAC2 - prostate cancer", "reltypes": "REGULATES_GrG - ASSOCIATES_DaG", "nodelabels": "Gene - Gene - Disease"}, {"pathid": 20, "rel_score": 2.43031, "prob_score": -0.41146788, "relevant": "1", "stops": "ILK - ENTPD6 - prostate cancer", "reltypes": "REGULATES_GrG - UPREGULATES_DuG", "nodelabels": "Gene - Gene - Disease"}]}
{"qid": "37", "sentence": "Overexpressing <e1> PKIB </e1> in <e2> prostate cancer </e2> promotes its aggressiveness by linking between PKA and Akt pathways.", "e1": "PKIB", "e2": "prostate cancer", "llm_pred": "1", "ground_truth": "1", "metapaths": [{"pathid": 10, "rel_score": 5.1999, "prob_score": -0.1981, "relevant": "1", "stops": "PKIB - liver - SQRDL - Lenalidomide - Prostate cancer metastatic", "reltypes": "EXPRESSES_AeG - EXPRESSES_AeG - UPREGULATES_CuG - CAUSES_CcSE", "nodelabels": "Gene - Anatomy - Gene - Compound - SideEffect"}, {"pathid": 32, "rel_score": 5.0702, "prob_score": -0.2023, "relevant": "1", "stops": "PKIB - female reproductive system - SQRDL - Lenalidomide - Prostate cancer metastatic", "reltypes": "EXPRESSES_AeG - EXPRESSES_AeG - UPREGULATES_CuG - CAUSES_CcSE", "nodelabels": "Gene - Anatomy - Gene - Compound - SideEffect"}, {"pathid": 41, "rel_score": 5.0482, "prob_score": -0.1923, "relevant": "1", "stops": "PKIB - prostate gland - SQRDL - Lenalidomide - Prostate cancer metastatic", "reltypes": "EXPRESSES_AeG - EXPRESSES_AeG - UPREGULATES_CuG - CAUSES_CcSE", "nodelabels": "Gene - Anatomy - Gene - Compound - SideEffect"}, {"pathid": 36, "rel_score": 4.9436, "prob_score": -0.1972, "relevant": "1", "stops": "PKIB - telencephalon - SQRDL - Lenalidomide - Prostate cancer metastatic", "reltypes": "EXPRESSES_AeG - DOWNREGULATES_AdG - UPREGULATES_CuG - CAUSES_CcSE", "nodelabels": "Gene - Anatomy - Gene - Compound - SideEffect"}, {"pathid": 31, "rel_score": 4.8586, "prob_score": -0.2058, "relevant": "1", "stops": "PKIB - nervous system - SQRDL - Lenalidomide - Prostate cancer metastatic", "reltypes": "EXPRESSES_AeG - EXPRESSES_AeG - UPREGULATES_CuG - CAUSES_CcSE", "nodelabels": "Gene - Anatomy - Gene - Compound - SideEffect"}, {"pathid": 26, "rel_score": 4.6694, "prob_score": -0.2142, "relevant": "1", "stops": "PKIB - brain - SQRDL - Lenalidomide - Prostate cancer metastatic", "reltypes": "EXPRESSES_AeG - EXPRESSES_AeG - UPREGULATES_CuG - CAUSES_CcSE", "nodelabels": "Gene - Anatomy - Gene - Compound - SideEffect"}, {"pathid": 14, "rel_score": 4.5384, "prob_score": -0.2203, "relevant": "1", "stops": "PKIB - pituitary gland - SQRDL - Lenalidomide - Prostate cancer metastatic", "reltypes": "EXPRESSES_AeG - EXPRESSES_AeG - UPREGULATES_CuG - CAUSES_CcSE", "nodelabels": "Gene - Anatomy - Gene - Compound - SideEffect"}]}
{"qid": "39", "sentence": "In human <e2> prostate cancer </e2> cells, knockdown of ILK expression with siRNA, or inhibition of ILK activity, results in significant inhibition of <e1> HIF-1alpha </e1> and VEGF expression.", "e1": "HIF-1alpha", "e2": "prostate cancer", "llm_pred": "0", "ground_truth": "0", "metapaths": [{"pathid": 9, "rel_score": 3.74995, "prob_score": -0.27688706, "relevant": "1", "stops": "HIF1AN - SEPT7 - prostate cancer", "reltypes": "REGULATES_GrG - DOWNREGULATES_DdG", "nodelabels": "Gene - Gene - Disease"}, {"pathid": 2, "rel_score": 3.67471, "prob_score": -0.26666713, "relevant": "1", "stops": "HIF1AN - HIF1A - prostate cancer", "reltypes": "INTERACTS_GiG - ASSOCIATES_DaG", "nodelabels": "Gene - Gene - Disease"}, {"pathid": 24, "rel_score": 3.61154, "prob_score": -0.28028747, "relevant": "1", "stops": "HIF1AN - HSPA1A - prostate cancer", "reltypes": "REGULATES_GrG - ASSOCIATES_DaG", "nodelabels": "Gene - Gene - Disease"}, {"pathid": 20, "rel_score": 3.56773, "prob_score": -0.27212733, "relevant": "1", "stops": "HIF1AN - LDHB - prostate cancer", "reltypes": "REGULATES_GrG - ASSOCIATES_DaG", "nodelabels": "Gene - Gene - Disease"}, {"pathid": 30, "rel_score": 3.39512, "prob_score": -0.29453713, "relevant": "1", "stops": "HIF1AN - JADE2 - Lenalidomide - Prostate cancer metastatic", "reltypes": "REGULATES_GrG - UPREGULATES_CuG - CAUSES_CcSE", "nodelabels": "Gene - Gene - Compound - SideEffect"}, {"pathid": 48, "rel_score": 3.20082, "prob_score": -0.31242493, "relevant": "1", "stops": "HIF1AN - PUF60 - Paroxetine - Prostate cancer", "reltypes": "REGULATES_GrG - DOWNREGULATES_CdG - CAUSES_CcSE", "nodelabels": "Gene - Gene - Compound - SideEffect"}, {"pathid": 36, "rel_score": 3.18512, "prob_score": -0.3139571, "relevant": "1", "stops": "HIF1AN - TMEM5 - Ruxolitinib - Prostate cancer", "reltypes": "REGULATES_GrG - DOWNREGULATES_CdG - CAUSES_CcSE", "nodelabels": "Gene - Gene - Compound - SideEffect"}]}
